Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Jonasch

Showing results (251-260 of 271) with videos related to

Pageof 28
Sort By:
The Lancet. Oncology|September 7, 2025
Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trialChad Tang, Alexander D Sherry, Aaron Seo, et al.
Science (New York, N.Y.)|July 21, 2018
VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinomaJing Zhang, Tao Wu, Jeremy Simon, et al.
Cancers|April 3, 2021
Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell CarcinomaEileen Shiuan, Anupama Reddy, Stephanie O Dudzinski, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2022
Noninvasive detection of any-stage cancer using free glycosaminoglycansSinisa Bratulic, Angelo Limeta, Saeed Dabestani, et al.
European Urology|January 24, 2025
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer TypesAxel Bex, Michael Jewett, Bryan Lewis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2014
Kidney cancer, version 2.2014Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 19, 2015
Testicular Cancer, Version 2.2015Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 19, 2015
Kidney cancer, version 3.2015Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Cancer|August 3, 2021
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statementGennady Bratslavsky, Neil Mendhiratta, Michael Daneshvar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2019
NCCN Guidelines Insights: Kidney Cancer, Version 2.2020Robert J Motzer, Eric Jonasch, M Dror Michaelson, et al.
Pageof 28

Showing results (251-260 of 271) with videos related to

Sort By:
Pageof 28
The Lancet. Oncology|September 7, 2025
Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trialChad Tang, Alexander D Sherry, Aaron Seo, et al.
Science (New York, N.Y.)|July 21, 2018
VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinomaJing Zhang, Tao Wu, Jeremy Simon, et al.
Cancers|April 3, 2021
Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell CarcinomaEileen Shiuan, Anupama Reddy, Stephanie O Dudzinski, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2022
Noninvasive detection of any-stage cancer using free glycosaminoglycansSinisa Bratulic, Angelo Limeta, Saeed Dabestani, et al.
European Urology|January 24, 2025
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer TypesAxel Bex, Michael Jewett, Bryan Lewis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2014
Kidney cancer, version 2.2014Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 19, 2015
Testicular Cancer, Version 2.2015Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 19, 2015
Kidney cancer, version 3.2015Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Cancer|August 3, 2021
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statementGennady Bratslavsky, Neil Mendhiratta, Michael Daneshvar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2019
NCCN Guidelines Insights: Kidney Cancer, Version 2.2020Robert J Motzer, Eric Jonasch, M Dror Michaelson, et al.
Pageof 28